<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Anesth Essays Res</journal-id><journal-id journal-id-type="iso-abbrev">Anesth Essays Res</journal-id><journal-id journal-id-type="publisher-id">AER</journal-id><journal-title-group><journal-title>Anesthesia, Essays and Researches</journal-title></journal-title-group><issn pub-type="ppub">0259-1162</issn><issn pub-type="epub">2229-7685</issn><publisher><publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25886427</article-id><article-id pub-id-type="pmc">4383102</article-id><article-id pub-id-type="publisher-id">AER-9-88</article-id><article-id pub-id-type="doi">10.4103/0259-1162.150676</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Comparison of equipotent doses of rocuronium and vecuronium</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Parasa</surname><given-names>Mrunalini</given-names></name><xref ref-type="aff" rid="aff1"></xref><xref ref-type="corresp" rid="cor1"></xref></contrib><contrib contrib-type="author"><name><surname>Vemuri</surname><given-names>Nagendra Nath</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Shaik</surname><given-names>Mastan Saheb</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib></contrib-group><aff id="aff1">Department of Anaesthesiology, NRI Medical College, Chinakakani, Guntur, Andhra Pradesh, India</aff><author-notes><corresp id="cor1">
Corresponding author: Dr. Mrunalini Parasa, NRI Medical College, Chinakakani, Guntur - 522 503, Andhra Pradesh, India. E-mail: <email xlink:href="parasamrunalini@hotmail.com">parasamrunalini@hotmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jan-Apr</season><year>2015</year></pub-date><volume>9</volume><issue>1</issue><fpage>88</fpage><lpage>91</lpage><permissions><copyright-statement>Copyright: © Anesthesia: Essays and Researches</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="2811" xml_f="2822" txt_i="11" txt_f="22">Background:</offsets></title><p><offsets xml_i="2833" xml_f="3044" txt_i="23" txt_f="234">Rocuronium (R) bromide and vecuronium (V) are monoquaternary aminosteroid compounds. The aim of this study was to evaluate the onset time, conditions of intubation and duration of action of equipotent doses (3ED</offsets><sub><offsets xml_i="3049" xml_f="3051" txt_i="234" txt_f="236">95</offsets></sub><offsets xml_i="3057" xml_f="3070" txt_i="236" txt_f="249">) of R and V.</offsets></p></sec><sec id="st2"><title><offsets xml_i="3101" xml_f="3123" txt_i="251" txt_f="273">Materials and Methods:</offsets></title><p><offsets xml_i="3134" xml_f="3590" txt_i="274" txt_f="730">The study was carried out in 60 adult American Society of Anesthesiologists physical status 1–2 patients of age 20–60 years. The patients were divided into two groups of 30 each and received either 0.9 mg/kg of R (Group R) or 0.168 mg/kg of V (Group V) to facilitate endotracheal intubation. Neuromuscular blockade was assessed at corrugator supercilii and adductor pollicis muscles to evaluate onset time and duration of neuromuscular block, respectively.</offsets></p></sec><sec id="st3"><title><offsets xml_i="3621" xml_f="3629" txt_i="732" txt_f="740">Results:</offsets></title><p><offsets xml_i="3640" xml_f="3719" txt_i="741" txt_f="820">The mean onset time was significantly rapid in Group R as compared to Group V (</offsets><italic><offsets xml_i="3727" xml_f="3728" txt_i="820" txt_f="821">P</offsets></italic><offsets xml_i="3737" xml_f="3938" txt_i="821" txt_f="1022"> -0.011). Overall intubating conditions were excellent in 100% of patients in Group R as compared to 70% in Group V. The mean duration of action did not show a significant variation between the groups.</offsets></p></sec><sec id="st4"><title><offsets xml_i="3969" xml_f="3980" txt_i="1024" txt_f="1035">Conclusion:</offsets></title><p><offsets xml_i="3991" xml_f="4148" txt_i="1036" txt_f="1193">At equipotent doses, R provides clinically acceptable intubation conditions much earlier than V without significant variation in clinical duration of action.</offsets></p></sec></abstract><kwd-group><kwd>3ED<sub>95</sub></kwd><kwd>rocuronium</kwd><kwd>train of four</kwd><kwd>vecuronium</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title><offsets xml_i="4355" xml_f="4367" txt_i="1202" txt_f="1214">INTRODUCTION</offsets></title><p><offsets xml_i="4378" xml_f="5012" txt_i="1215" txt_f="1849">An ideal neuromuscular blocking agent for intubation should have a rapid onset, brief duration of action, provide excellent intubation conditions and should be free from side-effects. For several decades, suxamethonium was the gold standard relaxant for rapid sequence intubation. However, the unintended side-effects such as muscle fasciculations, hyperkalemia, rise in intracranial and intraocular pressures led to the search of newer relaxants. Though vecuronium (V) and atracurium were found to have shorter onset times than the older nondepolarizing muscle relaxants, they did not serve the purpose of rapid sequence intubation.[</offsets><xref rid="ref1" ref-type="bibr"><offsets xml_i="5045" xml_f="5046" txt_i="1849" txt_f="1850">1</offsets></xref><xref rid="ref2" ref-type="bibr"><offsets xml_i="5086" xml_f="5087" txt_i="1850" txt_f="1851">2</offsets></xref><offsets xml_i="5094" xml_f="5177" txt_i="1851" txt_f="1934">] Rocuronium (R) bromide a mono quaternary amino-steroid became available in 1994.[</offsets><xref rid="ref3" ref-type="bibr"><offsets xml_i="5210" xml_f="5211" txt_i="1934" txt_f="1935">3</offsets></xref><offsets xml_i="5218" xml_f="5393" txt_i="1935" txt_f="2110">] Because of its low potency (5.35 times) R is administered in a higher dose leading to high bioavailability at the neuromuscular junction resulting in rapid onset of action.[</offsets><xref rid="ref3" ref-type="bibr"><offsets xml_i="5426" xml_f="5427" txt_i="2110" txt_f="2111">3</offsets></xref><offsets xml_i="5434" xml_f="5468" txt_i="2111" txt_f="2145">] No previous studies compared 3ED</offsets><sub><offsets xml_i="5473" xml_f="5475" txt_i="2145" txt_f="2147">95</offsets></sub><offsets xml_i="5481" xml_f="5485" txt_i="2147" txt_f="2151"> (ED</offsets><sub><offsets xml_i="5490" xml_f="5492" txt_i="2151" txt_f="2153">95</offsets></sub><offsets xml_i="5498" xml_f="5695" txt_i="2153" txt_f="2350"> is the dose required to produce 95% depression of twitch response) of the two drugs. The purpose of this study was to compare the onset time, conditions at intubation and duration of action of 3ED</offsets><sub><offsets xml_i="5700" xml_f="5702" txt_i="2350" txt_f="2352">95</offsets></sub><offsets xml_i="5708" xml_f="5720" txt_i="2352" txt_f="2364"> of R and V.</offsets></p></sec><sec sec-type="materials|methods" id="sec1-2"><title><offsets xml_i="5783" xml_f="5804" txt_i="2366" txt_f="2387">MATERIALS AND METHODS</offsets></title><p><offsets xml_i="5815" xml_f="6142" txt_i="2388" txt_f="2715">After obtaining Institutional Ethical Committee approval and written informed consent, 60 American Society of Anesthesiologists (ASA) physical status 1–2 patients of either sex aged 20–60 years scheduled for various surgical procedures under general anesthesia were enrolled in this prospective, randomized, double-blind study.</offsets></p><p><offsets xml_i="6149" xml_f="6187" txt_i="2716" txt_f="2754">Patients with body mass index ≥40 kg/m</offsets><sup><offsets xml_i="6192" xml_f="6193" txt_i="2754" txt_f="2755">2</offsets></sup><offsets xml_i="6199" xml_f="6466" txt_i="2755" txt_f="3022">, anticipated difficult intubation or mask ventilation, hepatic or renal impairment, neuromuscular disorders, allergy to the study drugs and pregnancy were excluded from the study. Patients were allocated using random number tables into Group R or Group V of 30 each.</offsets></p><p><offsets xml_i="6473" xml_f="6563" txt_i="3023" txt_f="3113">All the patients were premedicated with tablet alprazolam 0.5 mg the night before surgery.</offsets></p><p><offsets xml_i="6570" xml_f="7950" txt_i="3114" txt_f="4494">Following placement of standard monitors and intravenous access, all the patients were preoxygenated with 100% oxygen for 3 min and received glycopyrrolate 5 μ/kg. Anesthesia was induced with 0.02 mg/kg midazolam, 1 μ/kg fentanyl and titrated doses of propofol until the loss of verbal contact. Train of four stimulus (TOF) of 4 pulses each of 0.2 ms duration at 2 Hz frequency was applied over 2 s to the temporal branch of facial nerve and the resultant twitches of corrugator supercilii (CS) muscle were observed visually. The patients were administered either 0.9 mg/kg R in Group R or 0.168 mg/kg V in Group V over 5 s into a fast flowing intravenous line to facilitate endotracheal intubation and were ventilated with 1% sevoflurane in oxygen. Onset of neuromuscular block was assessed with TOF stimulus every 15 s until the loss of visual response of CS muscle to stimulation of temporal branch of facial nerve. Onset time was the time from administration of muscle relaxant to the loss of visual response to the nerve stimulus. After achieving maximal neuromuscular block, endotracheal intubation was done within 10 s by the same skilled anesthetist who was not involved in the anesthesia technique and was consequently blinded to the neuromuscular blocking agent given and the observations. The conditions at intubation were assessed using the four-point scale of Cooper[</offsets><xref rid="ref4" ref-type="bibr"><offsets xml_i="7983" xml_f="7984" txt_i="4494" txt_f="4495">4</offsets></xref><xref rid="ref5" ref-type="bibr"><offsets xml_i="8024" xml_f="8025" txt_i="4495" txt_f="4496">5</offsets></xref><xref rid="ref6" ref-type="bibr"><offsets xml_i="8065" xml_f="8066" txt_i="4496" txt_f="4497">6</offsets></xref><offsets xml_i="8073" xml_f="8076" txt_i="4497" txt_f="4500">] [</offsets><xref ref-type="table" rid="T1"><offsets xml_i="8108" xml_f="8115" txt_i="4500" txt_f="4507">Table 1</offsets></xref><offsets xml_i="8122" xml_f="8168" txt_i="4507" txt_f="4553">], which was a modification of Krieg's scale.[</offsets><xref rid="ref7" ref-type="bibr"><offsets xml_i="8201" xml_f="8202" txt_i="4553" txt_f="4554">7</offsets></xref><offsets xml_i="8209" xml_f="8861" txt_i="4554" txt_f="5206">] Intubation was graded according to the score attained on Cooper scale as excellent (8–9), good (6–9), fair (3–5) or poor (0–2). TOF stimulus was repeated every 5 min till the recovery of the first twitch. Duration of action of muscle relaxant was assessed at adductor pollicis (AP) muscle and it was the time from administration of muscle relaxant to the recovery of first twitch in response to stimulation of ulnar nerve at the wrist. Normothermia was maintained in patients of both the groups. The primary outcome measure of the study was the onset time. The secondary outcome measures were the conditions of intubation and duration of action of R.</offsets></p><table-wrap id="T1" position="float"><label><offsets xml_i="8909" xml_f="8916" txt_i="5207" txt_f="5214">Table 1</offsets></label><caption><p><offsets xml_i="8936" xml_f="8997" txt_i="5214" txt_f="5275">Criteria and score of conditions of intubation (Cooper scale)</offsets></p></caption><graphic xlink:href="AER-9-88-g001"></graphic></table-wrap><sec id="sec2-1"><title><offsets xml_i="9094" xml_f="9114" txt_i="5276" txt_f="5296">Statistical analysis</offsets></title><p><offsets xml_i="9125" xml_f="9572" txt_i="5297" txt_f="5744">Sample size was derived using MedCalc (trial version 11) online power and sample size calculator based on the assumption of alpha error 0.05 and power of the study were 86%. MedCalc statistical software, version (13.3) was used to analyze the data. Summary statistics, mean and standard deviation were calculated for different parameters under the study. The observed results were analyzed using Chi-square test for qualitative data and Student's </offsets><italic><offsets xml_i="9580" xml_f="9581" txt_i="5744" txt_f="5745">t</offsets></italic><offsets xml_i="9590" xml_f="9619" txt_i="5745" txt_f="5774">-test for quantitative data. </offsets><italic><offsets xml_i="9627" xml_f="9628" txt_i="5774" txt_f="5775">P</offsets></italic><offsets xml_i="9637" xml_f="9692" txt_i="5775" txt_f="5827"> &lt; 0.05 was considered as statistically significant.</offsets></p></sec></sec><sec sec-type="results" id="sec1-3"><title><offsets xml_i="9751" xml_f="9758" txt_i="5830" txt_f="5837">RESULTS</offsets></title><p><offsets xml_i="9769" xml_f="10069" txt_i="5838" txt_f="6138">From the initial study group of 68 patients, 8 patients (four from each group) were excluded from the study because the neuromuscular block was incomplete 5 min after injection of muscle relaxant. The groups were comparable with respect to demographic data, ASA physical status and Mallampati score [</offsets><xref ref-type="table" rid="T2"><offsets xml_i="10101" xml_f="10108" txt_i="6138" txt_f="6145">Table 2</offsets></xref><offsets xml_i="10115" xml_f="10234" txt_i="6145" txt_f="6264">]. The mean onset time was significantly rapid in Group R (83.66 ± 41.73 s), compared with Group V (116.66 ± 55.37 s) [</offsets><xref ref-type="table" rid="T3"><offsets xml_i="10266" xml_f="10273" txt_i="6264" txt_f="6271">Table 3</offsets></xref><offsets xml_i="10280" xml_f="10395" txt_i="6271" txt_f="6386">]. There was a statistically significant difference in mean onset time in both groups with rapid onset in Group R (</offsets><italic><offsets xml_i="10403" xml_f="10404" txt_i="6386" txt_f="6387">P</offsets></italic><offsets xml_i="10413" xml_f="10810" txt_i="6387" txt_f="6784"> - 0.011). Overall intubation conditions were excellent in 100% of patients in Group R as compared to 70% patients in Group V. Intubation conditions were good in 23% and fair in 7% of patients in Group V. The mean duration of action in Group R was 49.83 ± 14.53 min, compared to Group V 52.5 ± 15.9 min. There was no statistically significant difference in mean duration of action in both groups (</offsets><italic><offsets xml_i="10818" xml_f="10819" txt_i="6784" txt_f="6785">P</offsets></italic><offsets xml_i="10828" xml_f="10837" txt_i="6785" txt_f="6794"> - 0.50).</offsets></p><table-wrap id="T2" position="float"><label><offsets xml_i="10885" xml_f="10892" txt_i="6795" txt_f="6802">Table 2</offsets></label><caption><p><offsets xml_i="10912" xml_f="10928" txt_i="6802" txt_f="6818">Demographic data</offsets></p></caption><graphic xlink:href="AER-9-88-g002"></graphic></table-wrap><table-wrap id="T3" position="float"><label><offsets xml_i="11045" xml_f="11052" txt_i="6819" txt_f="6826">Table 3</offsets></label><caption><p><offsets xml_i="11072" xml_f="11154" txt_i="6826" txt_f="6908">Onset time, duration of action and conditions of intubation in R Group and V Group</offsets></p></caption><graphic xlink:href="AER-9-88-g003"></graphic></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title><offsets xml_i="11279" xml_f="11289" txt_i="6910" txt_f="6920">DISCUSSION</offsets></title><p><offsets xml_i="11300" xml_f="11624" txt_i="6921" txt_f="7245">The study has confirmed the rapid onset of action of R compared with V. It also showed that the clinical conditions of intubation were better with R than V. Onset of action at CS muscle did not guarantee excellent intubation conditions in V Group. Both the groups did not show a significant difference in duration of action.</offsets></p><p><offsets xml_i="11631" xml_f="11702" txt_i="7246" txt_f="7317">Many previous studies compared R with V. However, no study compared 3ED</offsets><sub><offsets xml_i="11707" xml_f="11709" txt_i="7317" txt_f="7319">95</offsets></sub><offsets xml_i="11715" xml_f="11856" txt_i="7319" txt_f="7460"> of the two drugs. Onset time at CS with either of the relaxants and its correlation with conditions at intubation were also not assessed. ED</offsets><sub><offsets xml_i="11861" xml_f="11863" txt_i="7460" txt_f="7462">95</offsets></sub><offsets xml_i="11869" xml_f="12023" txt_i="7462" txt_f="7616">, corresponding to 95% block, is more commonly used to compare the pharmacological profile of drugs. R bromide is 5.35 times less potent than V with an ED</offsets><sub><offsets xml_i="12028" xml_f="12030" txt_i="7616" txt_f="7618">95</offsets></sub><offsets xml_i="12036" xml_f="12080" txt_i="7618" txt_f="7662"> of 0.3 mg/kg and 0.056 mg/kg respectively.[</offsets><xref rid="ref3" ref-type="bibr"><offsets xml_i="12113" xml_f="12114" txt_i="7662" txt_f="7663">3</offsets></xref><offsets xml_i="12121" xml_f="12122" txt_i="7663" txt_f="7664">]</offsets></p><p><offsets xml_i="12129" xml_f="12578" txt_i="7665" txt_f="8114">As the muscles of interest (diaphragm, abdominal or laryngeal muscles) are clinically not accessible, it would be appropriate to choose a site that has a similar response to the muscles of interest. We chose CS to assess the onset of action as the response of the CS is close to that of the laryngeal muscles. Even though, cessation of response of orbicularis occuli occurs earlier than CS, it does not guarantee satisfactory intubation conditions.[</offsets><xref rid="ref8" ref-type="bibr"><offsets xml_i="12611" xml_f="12612" txt_i="8114" txt_f="8115">8</offsets></xref><xref rid="ref9" ref-type="bibr"><offsets xml_i="12652" xml_f="12653" txt_i="8115" txt_f="8116">9</offsets></xref><offsets xml_i="12660" xml_f="12805" txt_i="8116" txt_f="8261">] Though excellent intubation conditions were observed most frequently with neuromuscular block assessment at AP, it delays the intubation time.[</offsets><xref rid="ref8" ref-type="bibr"><offsets xml_i="12838" xml_f="12839" txt_i="8261" txt_f="8262">8</offsets></xref><offsets xml_i="12846" xml_f="12967" txt_i="8262" txt_f="8383">] CS can predict the presence of excellent tracheal intubation conditions and allows intubation earlier than that of AP.[</offsets><xref rid="ref8" ref-type="bibr"><offsets xml_i="13000" xml_f="13001" txt_i="8383" txt_f="8384">8</offsets></xref><xref rid="ref10" ref-type="bibr"><offsets xml_i="13042" xml_f="13044" txt_i="8384" txt_f="8386">10</offsets></xref><offsets xml_i="13051" xml_f="13052" txt_i="8386" txt_f="8387">]</offsets></p><p><offsets xml_i="13059" xml_f="13698" txt_i="8388" txt_f="9027">Conditions at intubation were assessed in our study as the muscle groups differ in their sensitivity to neuromuscular blocking agents. The central group of muscles show an early onset of action compared to the peripheral muscles. Among the central group of muscles, diaphragm and laryngeal adductors are most resistant to the action of nondepolarizing neuromuscular blockers. Hence, the results obtained from one muscle cannot be extrapolated to the other. Use of a peripheral nerve stimulator cannot replace direct observation of the muscles (larynx, and diaphragm) as the twitch height at one muscle does not parallel that of the other.[</offsets><xref rid="ref11" ref-type="bibr"><offsets xml_i="13732" xml_f="13734" txt_i="9027" txt_f="9029">11</offsets></xref><xref rid="ref12" ref-type="bibr"><offsets xml_i="13775" xml_f="13777" txt_i="9029" txt_f="9031">12</offsets></xref><offsets xml_i="13784" xml_f="13785" txt_i="9031" txt_f="9032">]</offsets></p><p><offsets xml_i="13792" xml_f="13979" txt_i="9033" txt_f="9220">Normothermia was maintained throughout the study as twitch tension is reduced by 61%/°C decrease in temperature of the monitored muscle group due to increasing in resistance of the skin.[</offsets><xref rid="ref11" ref-type="bibr"><offsets xml_i="14013" xml_f="14015" txt_i="9220" txt_f="9222">11</offsets></xref><offsets xml_i="14022" xml_f="14023" txt_i="9222" txt_f="9223">]</offsets></p><p><offsets xml_i="14030" xml_f="14656" txt_i="9224" txt_f="9850">Duration of action of muscle relaxants in the study was documented by assessing the response of AP to stimulation of ulnar nerve for two reasons. One was that head and neck surgeries were included in the study and AP provided easy access for neuromuscular monitoring. The second was that monitoring the response of AP during recovery reflects the upper airway muscles. As AP is one of the last muscles to recover from neuromuscular blockade (NMB), the recovery of the muscle indicates that diaphragm and other muscles have definitely recovered. It is essential to monitor AP to ensure full recovery of neuromuscular function.[</offsets><xref rid="ref13" ref-type="bibr"><offsets xml_i="14690" xml_f="14692" txt_i="9850" txt_f="9852">13</offsets></xref><xref rid="ref14" ref-type="bibr"><offsets xml_i="14733" xml_f="14735" txt_i="9852" txt_f="9854">14</offsets></xref><xref rid="ref15" ref-type="bibr"><offsets xml_i="14776" xml_f="14778" txt_i="9854" txt_f="9856">15</offsets></xref><offsets xml_i="14785" xml_f="14786" txt_i="9856" txt_f="9857">]</offsets></p><p><offsets xml_i="14793" xml_f="14814" txt_i="9858" txt_f="9879">High dose NMB (3–4 ED</offsets><sub><offsets xml_i="14819" xml_f="14821" txt_i="9879" txt_f="9881">95</offsets></sub><offsets xml_i="14827" xml_f="14955" txt_i="9881" txt_f="10009">) used for modified rapid sequence inductions, will prolong the duration (50–300%) of blockade compared with normal-dose (1–2 ED</offsets><sub><offsets xml_i="14960" xml_f="14962" txt_i="10009" txt_f="10011">95</offsets></sub><offsets xml_i="14968" xml_f="15112" txt_i="10011" txt_f="10155">). Hence, such dose cannot be used for short surgical procedures. Dosing should always be individualized to the anticipated duration of surgery.</offsets></p><p><offsets xml_i="15119" xml_f="15165" txt_i="10156" txt_f="10202">A study done by Patel and Swadia comparing 2ED</offsets><sub><offsets xml_i="15170" xml_f="15172" txt_i="10202" txt_f="10204">95</offsets></sub><offsets xml_i="15178" xml_f="15215" txt_i="10204" txt_f="10241"> of R and V, showed a significantly (</offsets><italic><offsets xml_i="15223" xml_f="15224" txt_i="10241" txt_f="10242">P</offsets></italic><offsets xml_i="15233" xml_f="15365" txt_i="10242" txt_f="10374"> - 0.001) shorter onset of rocuronim (75.66 ± 11.79 s) than V (116.66 ± 10.93) without significant variation in duration of action.[</offsets><xref rid="ref4" ref-type="bibr"><offsets xml_i="15398" xml_f="15399" txt_i="10374" txt_f="10375">4</offsets></xref><offsets xml_i="15406" xml_f="16193" txt_i="10375" txt_f="11162">] The response of orbicularis occuli muscle to stimulation of the facial nerve was monitored to assess the degree of NMB. Conditions at intubation were also better in R Group (excellent intubating conditions were recorded in 83.33% of R Group and 46.66% of patients in V Group). However, the intubation conditions in our study were better compared with their study and this could probably be attributed to a higher dose and the monitoring of the neuromuscular block at CS muscle. Onset time in R Group was shorter in their study despite a smaller dose compared to our study (83.66 ± 41.73 s) as orbicularis occuli is more sensitive to nondepolarizing neuromuscular blockers than CS, hence shows a rapid loss of response to TOF. Smith and Saad compared the intubating conditions after 2ED</offsets><sub><offsets xml_i="16198" xml_f="16200" txt_i="11162" txt_f="11164">95</offsets></sub><offsets xml_i="16206" xml_f="16219" txt_i="11164" txt_f="11177"> of R and V.[</offsets><xref rid="ref16" ref-type="bibr"><offsets xml_i="16253" xml_f="16255" txt_i="11177" txt_f="11179">16</offsets></xref><offsets xml_i="16262" xml_f="16466" txt_i="11179" txt_f="11383">] They judged the timing of intubation by clinical criteria and concluded that R provided better intubating conditions than V. Both the groups did not vary in hemodynamic responses to intubation. Doǧruel </offsets><italic><offsets xml_i="16474" xml_f="16479" txt_i="11383" txt_f="11388">et al</offsets></italic><offsets xml_i="16488" xml_f="16518" txt_i="11388" txt_f="11418">. used various doses of R (2ED</offsets><sub><offsets xml_i="16523" xml_f="16525" txt_i="11418" txt_f="11420">95</offsets></sub><offsets xml_i="16531" xml_f="16539" txt_i="11420" txt_f="11428"> and 4ED</offsets><sub><offsets xml_i="16544" xml_f="16546" txt_i="11428" txt_f="11430">95</offsets></sub><offsets xml_i="16552" xml_f="16564" txt_i="11430" txt_f="11442">) and V (2ED</offsets><sub><offsets xml_i="16569" xml_f="16571" txt_i="11442" txt_f="11444">95</offsets></sub><offsets xml_i="16577" xml_f="16696" txt_i="11444" txt_f="11563"> with and without priming) and neuromuscular block was monitored by the contraction of AP muscle by acceleromyography.[</offsets><xref rid="ref17" ref-type="bibr"><offsets xml_i="16730" xml_f="16732" txt_i="11563" txt_f="11565">17</offsets></xref><offsets xml_i="16739" xml_f="16848" txt_i="11565" txt_f="11674">] Intergroup comparisons revealed that time, to achieve complete blockade, was significantly shorter in R 4ED</offsets><sub><offsets xml_i="16853" xml_f="16855" txt_i="11674" txt_f="11676">95</offsets></sub><offsets xml_i="16861" xml_f="16990" txt_i="11676" txt_f="11805"> than other groups. There was no significant difference among groups with regards to the quality of intubation. A study by Sagir </offsets><italic><offsets xml_i="16998" xml_f="17003" txt_i="11805" txt_f="11810">et al</offsets></italic><offsets xml_i="17012" xml_f="17026" txt_i="11810" txt_f="11824">. compared 2ED</offsets><sub><offsets xml_i="17031" xml_f="17033" txt_i="11824" txt_f="11826">95</offsets></sub><offsets xml_i="17039" xml_f="17245" txt_i="11826" txt_f="12032"> of R, V and cisatracurium in elderly patients using accelomyography at AP and showed that intubation time was faster with R but cisatracurium had a better recovery profile and hence preferable in elderly.[</offsets><xref rid="ref18" ref-type="bibr"><offsets xml_i="17279" xml_f="17281" txt_i="12032" txt_f="12034">18</offsets></xref><offsets xml_i="17288" xml_f="17308" txt_i="12034" txt_f="12054">] A study by Somani </offsets><italic><offsets xml_i="17316" xml_f="17321" txt_i="12054" txt_f="12059">et al</offsets></italic><offsets xml_i="17330" xml_f="17340" txt_i="12059" txt_f="12069">. with 2ED</offsets><sub><offsets xml_i="17345" xml_f="17347" txt_i="12069" txt_f="12071">95</offsets></sub><offsets xml_i="17353" xml_f="17487" txt_i="12071" txt_f="12205"> of R and V using TOF guard monitor at AP showed early onset of action in R Group without significant difference in intubation sores.[</offsets><xref rid="ref19" ref-type="bibr"><offsets xml_i="17521" xml_f="17523" txt_i="12205" txt_f="12207">19</offsets></xref><offsets xml_i="17530" xml_f="17531" txt_i="12207" txt_f="12208">]</offsets></p><p><offsets xml_i="17538" xml_f="17735" txt_i="12209" txt_f="12406">One limitation of our study is the use of electrocardiography electrodes, that is, silver - chloride electrodes and they offer greater impedance than the electrodes recommended for NMJ monitoring.[</offsets><xref rid="ref15" ref-type="bibr"><offsets xml_i="17769" xml_f="17771" txt_i="12406" txt_f="12408">15</offsets></xref><offsets xml_i="17778" xml_f="17925" txt_i="12408" txt_f="12555">] Because of the lack of equipment neuromuscular function was assessed visually, and quantitative devices were not used to record the contractions.</offsets></p></sec><sec sec-type="conclusion" id="sec1-5"><title><offsets xml_i="17981" xml_f="17991" txt_i="12557" txt_f="12567">CONCLUSION</offsets></title><p><offsets xml_i="18002" xml_f="18036" txt_i="12568" txt_f="12602">In summary, onset of action of 3ED</offsets><sub><offsets xml_i="18041" xml_f="18043" txt_i="12602" txt_f="12604">95</offsets></sub><offsets xml_i="18049" xml_f="18184" txt_i="12604" txt_f="12739"> R is significantly shorter than V without significant variation in duration of action. R provides better intubation conditions than V.</offsets></p></sec></body><back><ack><title>ACKNOWLEDGMENT</title><p>I express my sincere gratitude to all my colleagues and my postgraduates for their co-operation and to Saritha for the assistance with statistical analysis.</p></ack><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Misra</surname><given-names>MN</given-names></name><name><surname>Agarwal</surname><given-names>M</given-names></name><name><surname>Pandey</surname><given-names>RP</given-names></name><name><surname>Gupta</surname><given-names>AA</given-names></name></person-group><article-title>Comparative study of rocuronium, vecuronium and succinylcholine for rapid sequence induction of anaesthesia</article-title><source>Indian J Anaesth</source><year>2005</year><volume>49</volume><fpage>469</fpage><lpage>73</lpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartkowski</surname><given-names>RR</given-names></name><name><surname>Witkowski</surname><given-names>TA</given-names></name><name><surname>Azad</surname><given-names>S</given-names></name><name><surname>Lessin</surname><given-names>J</given-names></name><name><surname>Marr</surname><given-names>A</given-names></name></person-group><article-title>Rocuronium onset of action: A comparison with atracurium and vecuronium</article-title><source>Anesth Analg</source><year>1993</year><volume>77</volume><fpage>574</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8103649</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>JM</given-names></name></person-group><article-title>Rocuronium: The newest aminosteroid neuromuscular blocking drug</article-title><source>Br J Anaesth</source><year>1996</year><volume>76</volume><fpage>481</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">8652315</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>DD</given-names></name><name><surname>Swadia</surname><given-names>VN</given-names></name></person-group><article-title>Rocuronium bromide versus vecuronium bromide: Comparision of onset, intubating condition and duration of action</article-title><source>Int J Res Med</source><year>2013</year><volume>2</volume><fpage>137</fpage><lpage>41</lpage></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parikh</surname><given-names>K</given-names></name><name><surname>Modh</surname><given-names>DB</given-names></name><name><surname>Upadhyay</surname><given-names>MR</given-names></name></person-group><article-title>Comparision of rocuronium bromide with suxamethonium chloride for tracheal intubation</article-title><source>Int J Med Sci Public Health</source><year>2014</year><volume>3</volume><fpage>611</fpage><lpage>5</lpage></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Passavanti</surname><given-names>MB</given-names></name><name><surname>Pace</surname><given-names>MC</given-names></name><name><surname>Sansone</surname><given-names>P</given-names></name><name><surname>Chiefari</surname><given-names>M</given-names></name><name><surname>Iannotti</surname><given-names>M</given-names></name><name><surname>Maisto</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Comparison of two rocuronium bromide doses in adult and elderly patients who underwent laparoscopic surgery</article-title><source>SAJAA</source><year>2008</year><volume>14</volume><fpage>19</fpage><lpage>23</lpage></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belekar</surname><given-names>VR</given-names></name><name><surname>Khamankar</surname><given-names>S</given-names></name></person-group><article-title>Rocuronium for tracheal intubation in patients undergoing emergency surgery</article-title><source>Int J Pharmacol Res</source><year>2013</year><volume>3</volume><fpage>18</fpage><lpage>22</lpage></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name><name><surname>Jeong</surname><given-names>JS</given-names></name><name><surname>Cheong</surname><given-names>MA</given-names></name><name><surname>Shim</surname><given-names>JC</given-names></name></person-group><article-title>Comparison of the adductor pollicis, orbicularis oculi, and corrugator supercilii as indicators of adequacy of muscle relaxation for tracheal intubation</article-title><source>Br J Anaesth</source><year>2009</year><volume>102</volume><fpage>869</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">19376787</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plaud</surname><given-names>B</given-names></name><name><surname>Debaene</surname><given-names>B</given-names></name><name><surname>Donati</surname><given-names>F</given-names></name></person-group><article-title>The corrugator supercilii, not the orbicularis oculi, reflects rocuronium neuromuscular blockade at the laryngeal adductor muscles</article-title><source>Anesthesiology</source><year>2001</year><volume>95</volume><fpage>96</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">11465590</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemmerling</surname><given-names>TM</given-names></name><name><surname>Schmidt</surname><given-names>J</given-names></name><name><surname>Hanusa</surname><given-names>C</given-names></name><name><surname>Wolf</surname><given-names>T</given-names></name><name><surname>Schmitt</surname><given-names>H</given-names></name></person-group><article-title>Simultaneous determination of neuromuscular block at the larynx, diaphragm, adductor pollicis, orbicularis oculi and corrugator supercilii muscles</article-title><source>Br J Anaesth</source><year>2000</year><volume>85</volume><fpage>856</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">11732519</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>John</surname><given-names>FB</given-names></name><name><surname>David</surname><given-names>CM</given-names></name><name><surname>John</surname><given-names>DW</given-names></name></person-group><article-title>Non Cardiovascular Monitoring</article-title><source>Morgan and Milhail's clinical Anaesthesiology</source><year>2013</year><edition>5th ed</edition><publisher-loc>New Yark</publisher-loc><publisher-name>Mc Graw Hill Publishers</publisher-name><fpage>123</fpage><lpage>42</lpage></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mongensen</surname><given-names>JV</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Ronald</surname><given-names>DM</given-names></name></person-group><article-title>Neuromuscular monitoring</article-title><source>Miller's Anaesthesia</source><year>2006</year><edition>6th ed</edition><publisher-loc>Philadelphia, Pennsylvania</publisher-loc><publisher-name>Churchill Livingston</publisher-name><fpage>1551</fpage><lpage>69</lpage></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghai</surname><given-names>B</given-names></name><name><surname>Makkar</surname><given-names>JK</given-names></name><name><surname>Wig</surname><given-names>J</given-names></name></person-group><article-title>Neuromuscular monitoring: A review</article-title><source>J Anaesth Clin Pharmacol</source><year>2006</year><volume>22</volume><fpage>347</fpage><lpage>56</lpage></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunes</surname><given-names>TS</given-names></name></person-group><article-title>Evaluation of orbicularis oculi, adductor pollicis and flexor hallux muscles responses to train of four stimulation</article-title><source>Rev Bras Anestesiol</source><year>2001</year><volume>51</volume><fpage>311</fpage><lpage>8</lpage></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padmaja</surname><given-names>D</given-names></name><name><surname>Mantha</surname><given-names>S</given-names></name></person-group><article-title>Monitoring of neuromuscular junction</article-title><source>Indian J Anaesth</source><year>2002</year><volume>46</volume><fpage>279</fpage><lpage>88</lpage></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>I</given-names></name><name><surname>Saad</surname><given-names>RS</given-names></name></person-group><article-title>Comparison of intubating conditions after rocuronium or vecuronium when the timing of intubation is judged by clinical criteria</article-title><source>Br J Anaesth</source><year>1998</year><volume>80</volume><fpage>235</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9602591</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doðruel</surname><given-names>B</given-names></name><name><surname>Varnalı</surname><given-names>G</given-names></name><name><surname>Selek</surname><given-names>C</given-names></name><name><surname>Telci</surname><given-names>L</given-names></name><name><surname>Akıncı</surname><given-names>IO</given-names></name></person-group><article-title>Comparison of different induction doses of rocuronium and vecuronium in neuroanaesthesia practice</article-title><source>Turk J Anaesth Reanim</source><year>2014</year><volume>42</volume><fpage>6</fpage><lpage>11</lpage></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagir</surname><given-names>O</given-names></name><name><surname>Yucesoy</surname><given-names>Noyan F</given-names></name><name><surname>Koroglu</surname><given-names>A</given-names></name><name><surname>Cicek</surname><given-names>M</given-names></name><name><surname>Ilksen</surname><given-names>Toprak H</given-names></name></person-group><article-title>Comparison between the effects of rocuronium, vecuronium, and cisatracurium using train-of-four and clinical tests in elderly patients</article-title><source>Anesth Pain Med</source><year>2013</year><volume>2</volume><fpage>142</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">24223350</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somani</surname><given-names>M</given-names></name><name><surname>Sharma</surname><given-names>P</given-names></name><name><surname>Sachdev</surname><given-names>S</given-names></name><name><surname>Mathur</surname><given-names>V</given-names></name><name><surname>Chaturvedi</surname><given-names>S</given-names></name></person-group><article-title>A comparitive study between vecuronium and rocuronium for intubating condition and hemodynamic changes</article-title><source>IOSR J Dent Med Sci</source><year>2014</year><volume>13</volume><fpage>33</fpage><lpage>9</lpage></element-citation></ref></ref-list></back></article>